首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1800767

2025 年至 2033 年栓塞保護裝置市場報告（按產品、應用、程序、材料、用途、最終用戶和地區）

Embolic Protection Devices Market Report by Product, Application, Procedure, Material, Usage, End-User, and Region 2025-2033

出版日期: 2025年08月01日 | 出版商:

IMARC | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2024年，全球栓塞防護裝置市場規模達12.393億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到22.921億美元，2025-2033年期間的複合年成長率（CAGR）為6.72%。微創手術認知度的不斷提升、心血管疾病盛行率的不斷上升以及醫療技術的不斷進步是推動市場發展的主要因素。

栓塞保護裝置是一種專門設計的醫療工具，旨在防止微創手術（尤其是在心血管介入手術中）中碎屑、血塊或其他潛在有害顆粒的遷移。這些裝置可作為過濾器或屏障，捕獲並控制可能通過血流傳播並導致中風或器官損傷等併發症的栓塞物。透過保護重要動脈並降低栓塞風險，這些裝置可提高血管成形術、支架置入術和動脈粥狀硬化斑塊切除術等手術的安全性和成功率。因此，栓塞保護裝置在整個醫療保健產業中廣泛應用，因為它們在最大限度地降低栓塞引起的術後併發症風險方面發揮著至關重要的作用，從而保障患者的健康。

隨著動脈粥狀硬化和冠狀動脈疾病等心血管疾病的盛行率不斷上升，用於降低介入治療期間栓塞風險的栓塞保護裝置的需求不斷成長，這將刺激預測期內栓塞保護裝置市場的成長。此外，微創技術在各醫學專業的應用日益廣泛，也增加了對栓塞保護裝置的需求。這些裝置對於在血管成形術、支架置放術和經導管主動脈瓣置換術等複雜手術中保障病患安全至關重要。除此之外，包括改進的過濾器設計和材料創新在內的許多技術進步提高了性能和患者治療效果，正在推動市場成長。此外，對減少術後併發症和住院時間的高度重視加速了栓塞保護裝置的採用，因為它有助於預防栓塞事件，從而促進了市場的成長。

栓塞保護裝置市場趨勢/促進因素：

心血管疾病盛行率上升

動脈粥狀硬化和冠狀動脈疾病等心血管疾病的激增是栓塞保護裝置市場的主要驅動力。隨著全球人口老化和生活方式因素加劇全球健康問題，血管成形術和支架置入等干涉措施正變得越來越普遍。栓塞保護裝置在降低栓塞風險方面發揮關鍵作用，栓塞是一種潛在的併發症，可能導致中風等嚴重後果。透過在手術過程中捕獲和控制碎屑，這些裝置可以顯著提高患者安全性和整體手術效果。栓塞保護裝置需求的不斷成長源於醫療保健專業人員致力於應對全球日益加重的心血管疾病負擔，並最大限度地降低相關手術風險。

越來越傾向微創手術

微創技術在各醫學專科領域的應用日益廣泛，刺激了對栓塞防護裝置的需求。這些裝置對於確保患者在經導管介入等栓塞風險較高的手術中的安全至關重要。隨著患者和醫護人員越來越傾向於微創手術，以加快康復速度並縮短住院時間，對有效的栓塞防護的需求變得至關重要。這些裝置對各種微創 (MI) 手術的適應性凸顯了其在現代醫療實踐中的重要性，在最佳化患者預後和手術成功率方面發揮著至關重要的作用。

科技快速進步

器械技術的持續創新，包括改進的過濾器設計、先進的材料和改進的部署機制，是栓塞保護器械市場的關鍵驅動力。醫療保健專業人員尋求能夠在介入過程中提供更高性能和更高安全性的工具。栓塞保護器械的演變有效地滿足了這些需求，提供了更佳的碎片捕獲能力、更精簡的手術流程並改善了患者預後。隨著醫療領域越來越重視能夠同時提升手術效果和病人福祉的新型解決方案，對先進栓塞保護器械的追求推動了市場的發展，為醫務人員及其服務的患者帶來了顯著的益處。

The global embolic protection devices market size reached USD 1,239.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,292.1 Million by 2033, exhibiting a growth rate (CAGR) of 6.72% during 2025-2033. The increasing awareness of minimally invasive procedures, rising prevalence of cardiovascular diseases, and numerous advancements in medical technology are some of the major factors propelling the market.

Embolic protection devices are specialized medical tools designed to prevent the migration of debris, blood clots, or other potentially harmful particles during minimally invasive procedures, particularly in cardiovascular interventions. These devices act as filters or barriers, capturing and containing emboli that could otherwise travel through the bloodstream and cause complications such as stroke or organ damage. By safeguarding vital arteries and reducing the risk of embolization, these devices improve the safety and success rates of procedures like angioplasty, stent placement, and atherectomy. As a result, embolic protection devices find extensive applications across the healthcare industry as they play a crucial role in preserving patient well-being by minimizing the potential for post-procedural complications arising from embolism.

The rising demand for embolic protection devices to mitigate the risks of embolization during interventions due to the increasing prevalence of cardiovascular diseases such as atherosclerosis and coronary artery disease will stimulate the growth of the embolic protection devices market during the forecast period. Moreover, the increasing adoption of minimally invasive techniques across various medical specialties has augmented the demand for embolic protection devices. These devices are integral to preserving patient safety during complex procedures like angioplasty, stenting, and transcatheter aortic valve replacement. Apart from this, numerous technological advancements, including improved filter designs and material innovation, that enhance performance and patient outcomes, are propelling the market growth. Furthermore, the heightened emphasis on reducing post-procedural complications and hospital stays has accelerated the adoption of embolic protection devices as it assists in preventing embolic events, thereby contributing to the market growth.

Embolic Protection Devices Market Trends/Drivers:

Rise in prevalence of cardiovascular diseases

The surge in cardiovascular diseases like atherosclerosis and coronary artery diseases acts as a primary driver in the embolic protection device market. With an aging global population and lifestyle factors contributing to health concerns worldwide, interventions such as angioplasty and stent placement are becoming more prevalent. Embolic protection devices play a critical role in mitigating the risks of embolization, a potential complication that can lead to severe consequences like stroke. By capturing and containing debris during these procedures, these devices significantly improve patient safety and overall procedural outcomes. The growing demand for embolic protection devices stems from healthcare professionals' commitment to addressing the mounting burden of cardiovascular diseases globally and minimizing the associated procedural risks.

Growing inclination toward minimally invasive procedures

The increasing adoption of minimally invasive techniques across diverse medical specialties stimulates the demand for embolic protection devices. These devices are essential for ensuring patient safety during procedures like transcatheter interventions, where the risk of embolization is significant. As patients and healthcare providers gravitate toward less invasive approaches, offering quicker recovery and shorter hospital stays, the need for effective embolic protection becomes paramount. The adaptability of these devices to various minimally invasive (MI) procedures underscores their significance in modern medical practice, where they play a crucial role in optimizing patient outcomes and procedural success.

Rapid technological advancements

Continuous innovations in device technology, including refined filter designs, advanced materials, and improved deployment mechanisms, are pivotal drivers of the embolic protection device market. Healthcare professionals seek tools that deliver enhanced performance and safety during interventions. The evolution of embolic protection devices effectively addresses these demands, providing better debris capture, streamlined procedures, and improved patient outcomes. As the medical field increasingly prioritizes novel solutions that enhance both procedural efficacy and patient well-being, the quest for sophisticated embolic protection devices propel the market forward, offering significant benefits to medical practitioners and the patients they serve.

Embolic Protection Devices Industry Segmentation:

Breakup by Product:

Distal Filter Devices
Distal Occlusion Devices
Proximal Occlusion Devices

Distal filter devices dominate the market

Distal filter devices have emerged as a driving force within the embolic protection devices market due to their pivotal role in minimizing embolic events during interventional procedures. These devices employ finely engineered filters positioned downstream to capture and contain debris released during procedures such as transcatheter interventions and angioplasty. By effectively intercepting emboli and preventing their migration to vital vessels, distal filter devices significantly mitigate the risk of complications, notably strokes.

Moreover, the growing recognition of their efficacy in preserving cerebral and peripheral circulation has spurred their adoption among healthcare professionals, leading to an increased demand for such devices. As a result, distal filter devices have enhanced patient outcomes and safety while supporting the overall growth trajectory of the embolic protection devices industry, underscoring their significance in modern medical interventions.

Breakup by Application:

Coronary Artery Treatment
Carotid Artery Treatment
Others

Coronary artery treatment holds the largest share in the market

Coronary artery treatment devices exert a substantial influence on the embolic protection devices market by addressing the inherent risk of embolic events in coronary interventions. These devices encompass a wide range of advanced technologies, including stents, angioplasty balloons, and atherectomy systems, all of which hold the potential to dislodge embolic debris during procedures. To counter this risk, embolic protection devices are integrated to capture and contain such debris, preventing its migration and minimizing adverse outcomes.

Furthermore, the growing demand for effective embolic protection strategies in coronary interventions has accelerated the adoption of dedicated embolic protection devices, as they strengthen the safety profile of coronary procedures, reducing the likelihood of complications such as myocardial infarctions and strokes. This symbiotic relationship between coronary artery treatment devices and embolic protection devices underscores their collective role in enhancing patient care and shaping the evolving landscape of cardiovascular interventions.

Breakup by Procedure:

Percutaneous Coronary Intervention
Carotid Artery Stenosis
Saphenous Vein Graft Intervention
Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement)
Others

Percutaneous coronary intervention represents the most widely used procedure

Percutaneous coronary intervention (PCI) significantly influences the embolic protection devices market due to its widespread use in treating coronary artery disease. PCI procedures involve the deployment of stents and other devices to open narrowed or blocked coronary arteries. However, these interventions carry the risk of embolic debris dislodgement, potentially leading to adverse events.

Furthermore, embolic protection devices play a crucial role in mitigating this risk by capturing and containing such debris, thereby reducing the chance of downstream embolization and associated complications. As PCI procedures continue to be a cornerstone of coronary artery disease management, the demand for effective embolic protection strategies has increased, fueling the growth of the market for embolic protection devices. This interdependence underscores the vital role of embolic protection devices in fortifying the safety and efficacy of percutaneous coronary interventions.

Breakup by Material:

Nitinol
Polyurethane

Nitinol represents the most popular material

Nitinol, a shape memory alloy with remarkable flexibility and thermal properties, plays a crucial role in driving the embolic protection devices market. This material's unique attributes make it an ideal choice for constructing filters and frames in embolic protection devices. Nitinol's ability to undergo controlled deformation and return to its original shape when exposed to heat enables the creation of intricate yet resilient designs that can navigate tortuous vessels while maintaining structural integrity. This exceptional combination of properties enhances the performance of embolic protection devices by ensuring optimal vessel coverage and debris capture. As healthcare professionals seek devices that offer both efficacy and adaptability during interventions, Nitinol-based embolic protection devices stand out as an essential driver in shaping the market's growth, ultimately contributing to improved patient outcomes in various vascular procedures.

Breakup by Usage:

Disposable Devices
Re-Usable Devices

Disposable devices account for the majority of the market share

Disposable devices aids in addressing critical concerns related to infection control, convenience, and cost-effectiveness. These disposable devices, designed for single-use applications, eliminate the need for reprocessing and sterilization, thereby minimizing the risk of cross-contamination and enhancing procedural efficiency. Moreover, they offer healthcare providers a hassle-free solution that reduces the burden of equipment maintenance.

Furthermore, the escalating demand for infection prevention measures and streamlined workflows has fueled the adoption of disposable embolic protection devices in various interventional procedures, spanning from endovascular interventions to transcatheter techniques. As medical settings prioritize patient safety and operational ease, the prominence of disposable embolic protection devices continues to escalate, substantiating their pivotal role in catalyzing the growth and evolution of the embolic protection devices market.

Breakup by End-User:

Hospitals and Clinics
Ambulatory Surgical Centers
Others

Hospitals and clinics represent the leading end user segment

As healthcare facilities, such as hospitals and clinics, continually strive to enhance patient outcomes and safety, the demand for effective embolic protection strategies has grown.

Moreover, hospitals and clinics actively seek advanced embolic protection devices to integrate into various interventional procedures, such as angioplasty, stent placement, and transcatheter interventions. The imperative to minimize the risk of embolic events, coupled with the need for streamlined procedural workflows, accelerates the adoption of these devices. Furthermore, as healthcare providers prioritize evidence-based practices, the utilization of embolic protection devices aligns with best practices for reducing complications and improving patient care, thus solidifying hospitals and clinics as key drivers in shaping the embolic protection devices market's expansion.

Breakup by Region:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest share in the market due to its robust healthcare infrastructure, technological advancements, and high prevalence of cardiovascular diseases. The region's well-established healthcare facilities, coupled with a strong emphasis on patient safety and outcomes, catalyze the demand for effective embolic protection strategies. Favorable reimbursement policies and a propensity for adopting innovative medical technologies further stimulate the adoption of embolic protection devices in diverse cardiovascular interventions.

Additionally, the presence of various key players in the region and ongoing research initiatives contribute to the continuous evolution of embolic protection technologies. With its combination of clinical need, economic factors, and technological readiness, North America has emerged as a leading regional market for embolic protection devices.

Competitive Landscape:

Key players in the embolic protection devices market have recently introduced noteworthy innovations to address critical challenges. They have unveiled advanced embolic protection devices with improved navigational capabilities, real-time monitoring features, and enhanced thrombus capture efficiency. These innovations aim to provide healthcare professionals with greater precision and insight during complex procedures like transcatheter interventions and carotid artery stenting. Furthermore, the leading players have invested in developing integrated systems that seamlessly integrate with existing procedural workflows, streamlining the process and minimizing procedural time. These advancements reflect the industry's commitment to refining embolic protection strategies and reinforcing patient safety, thereby solidifying their role as frontrunners in shaping the landscape of embolic protection technologies. We also expect the market to witness new entrants, consolidation of product portfolios, and increased collaborations among manufacturers to drive healthy competition within the embolic protection devices domain.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories
Allium Medical Solutions Ltd.
Boston Scientific Corporation
Cardinal Health Inc.
Contego Medical LLC
Innovative Cardiovascular Solutions LLC
Edwards Lifesciences Corporation
Medtronic Inc.
Silk Road Medical Inc.

Key Questions Answered in This Report

1.What was the size of the global embolic protection devices market in 2024?
2.What is the expected growth rate of the global embolic protection devices market during 2025-2033?
3.What has been the impact of COVID-19 on the global embolic protection devices market?
4.What are the key factors driving the global embolic protection devices market?
5.What is the breakup of the global embolic protection devices market based on the product?
6.What is the breakup of the global embolic protection devices market based on the application?
7.What is the breakup of the global embolic protection devices market based on the procedure?
8.What is the breakup of the global embolic protection devices market based on the material?
9.What is the breakup of the global embolic protection devices market based on the usage?
10.What is the breakup of the global embolic protection devices market based on the end-user?
11.What are the key regions in the global embolic protection devices market?
12.Who are the key players/companies in the global embolic protection devices market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Embolic Protection Devices Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Distal Filter Devices
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Distal Occlusion Devices
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Proximal Occlusion Devices
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Application

7.1 Coronary Artery Treatment
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Carotid Artery Treatment
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Procedure

8.1 Percutaneous Coronary Intervention
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Carotid Artery Stenosis
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Saphenous Vein Graft Intervention
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement)
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by Material

9.1 Nitinol
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Polyurethane
- 9.2.1 Market Trends
- 9.2.2 Market Forecast

10 Market Breakup by Usage

10.1 Disposable Devices
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Re-Usable Devices
- 10.2.1 Market Trends
- 10.2.2 Market Forecast

11 Market Breakup by End-User

11.1 Hospitals and Clinics
- 11.1.1 Market Trends
- 11.1.2 Market Forecast
11.2 Ambulatory Surgical Centers
- 11.2.1 Market Trends
- 11.2.2 Market Forecast
11.3 Others
- 11.3.1 Market Trends
- 11.3.2 Market Forecast

12 Market Breakup by Region

12.1 North America
- 12.1.1 United States
  - 12.1.1.1 Market Trends
  - 12.1.1.2 Market Forecast
- 12.1.2 Canada
  - 12.1.2.1 Market Trends
  - 12.1.2.2 Market Forecast
12.2 Asia Pacific
- 12.2.1 China
  - 12.2.1.1 Market Trends
  - 12.2.1.2 Market Forecast
- 12.2.2 Japan
  - 12.2.2.1 Market Trends
  - 12.2.2.2 Market Forecast
- 12.2.3 India
  - 12.2.3.1 Market Trends
  - 12.2.3.2 Market Forecast
- 12.2.4 South Korea
  - 12.2.4.1 Market Trends
  - 12.2.4.2 Market Forecast
- 12.2.5 Australia
  - 12.2.5.1 Market Trends
  - 12.2.5.2 Market Forecast
- 12.2.6 Indonesia
  - 12.2.6.1 Market Trends
  - 12.2.6.2 Market Forecast
- 12.2.7 Others
  - 12.2.7.1 Market Trends
  - 12.2.7.2 Market Forecast
12.3 Europe
- 12.3.1 Germany
  - 12.3.1.1 Market Trends
  - 12.3.1.2 Market Forecast
- 12.3.2 France
  - 12.3.2.1 Market Trends
  - 12.3.2.2 Market Forecast
- 12.3.3 United Kingdom
  - 12.3.3.1 Market Trends
  - 12.3.3.2 Market Forecast
- 12.3.4 Italy
  - 12.3.4.1 Market Trends
  - 12.3.4.2 Market Forecast
- 12.3.5 Spain
  - 12.3.5.1 Market Trends
  - 12.3.5.2 Market Forecast
- 12.3.6 Russia
  - 12.3.6.1 Market Trends
  - 12.3.6.2 Market Forecast
- 12.3.7 Others
  - 12.3.7.1 Market Trends
  - 12.3.7.2 Market Forecast
12.4 Latin America
- 12.4.1 Brazil
  - 12.4.1.1 Market Trends
  - 12.4.1.2 Market Forecast
- 12.4.2 Mexico
  - 12.4.2.1 Market Trends
  - 12.4.2.2 Market Forecast
- 12.4.3 Others
  - 12.4.3.1 Market Trends
  - 12.4.3.2 Market Forecast
12.5 Middle East and Africa
- 12.5.1 Market Trends
- 12.5.2 Market Breakup by Country
- 12.5.3 Market Forecast

13 SWOT Analysis

13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes

16 Price Indicators

17 Competitive Landscape

17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
- 17.3.1 Abbott Laboratories
  - 17.3.1.1 Company Overview
  - 17.3.1.2 Product Portfolio
  - 17.3.1.3 Financials
  - 17.3.1.4 SWOT Analysis
- 17.3.2 Allium Medical Solutions Ltd.
  - 17.3.2.1 Company Overview
  - 17.3.2.2 Product Portfolio
  - 17.3.2.3 Financials
- 17.3.3 Boston Scientific Corporation
  - 17.3.3.1 Company Overview
  - 17.3.3.2 Product Portfolio
  - 17.3.3.3 Financials
  - 17.3.3.4 SWOT Analysis
- 17.3.4 Cardinal Health Inc.
  - 17.3.4.1 Company Overview
  - 17.3.4.2 Product Portfolio
  - 17.3.4.3 Financials
  - 17.3.4.4 SWOT Analysis
- 17.3.5 Contego Medical LLC
  - 17.3.5.1 Company Overview
  - 17.3.5.2 Product Portfolio
- 17.3.6 Innovative Cardiovascular Solutions LLC
  - 17.3.6.1 Company Overview
  - 17.3.6.2 Product Portfolio
- 17.3.7 Edwards Lifesciences Corporation
  - 17.3.7.1 Company Overview
  - 17.3.7.2 Product Portfolio
  - 17.3.7.3 Financials
  - 17.3.7.4 SWOT Analysis
- 17.3.8 Medtronic Inc.
  - 17.3.8.1 Company Overview
  - 17.3.8.2 Product Portfolio
  - 17.3.8.3 Financials
  - 17.3.8.4 SWOT Analysis
- 17.3.9 Silk Road Medical Inc.
  - 17.3.9.1 Company Overview
  - 17.3.9.2 Product Portfolio
  - 17.3.9.3 Financials

簡介目錄圖表

List of Figures

Figure 1: Global: Embolic Protection Devices Market: Major Drivers and Challenges
Figure 2: Global: Embolic Protection Devices Market: Sales Value (in Million USD), 2019-2024
Figure 3: Global: Embolic Protection Devices Market: Breakup by Product (in %), 2024
Figure 4: Global: Embolic Protection Devices Market: Breakup by Application (in %), 2024
Figure 5: Global: Embolic Protection Devices Market: Breakup by Procedure (in %), 2024
Figure 6: Global: Embolic Protection Devices Market: Breakup by Material (in %), 2024
Figure 7: Global: Embolic Protection Devices Market: Breakup by Usage (in %), 2024
Figure 8: Global: Embolic Protection Devices Market: Breakup by End-User (in %), 2024
Figure 9: Global: Embolic Protection Devices Market: Breakup by Region (in %), 2024
Figure 10: Global: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Embolic Protection Devices (Distal Filter Devices) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Embolic Protection Devices (Distal Filter Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Embolic Protection Devices (Distal Occlusion Devices) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Embolic Protection Devices (Distal Occlusion Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Embolic Protection Devices (Proximal Occlusion Devices) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Embolic Protection Devices (Proximal Occlusion Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Embolic Protection Devices (Coronary Artery Treatment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Embolic Protection Devices (Coronary Artery Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Embolic Protection Devices (Carotid Artery Treatment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Embolic Protection Devices (Carotid Artery Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Embolic Protection Devices (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Embolic Protection Devices (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Embolic Protection Devices (Percutaneous Coronary Intervention) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Embolic Protection Devices (Percutaneous Coronary Intervention) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Embolic Protection Devices (Carotid Artery Stenosis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Embolic Protection Devices (Carotid Artery Stenosis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Embolic Protection Devices (Saphenous Vein Graft Intervention) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Embolic Protection Devices (Saphenous Vein Graft Intervention) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Embolic Protection Devices (Aortic Valve Stenosis- Transcatheter Aortic Valve Replacement) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Embolic Protection Devices (Aortic Valve Stenosis- Transcatheter Aortic Valve Replacement) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Embolic Protection Devices (Other Procedures) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Embolic Protection Devices (Other Procedures) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Embolic Protection Devices (Nitinol) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Embolic Protection Devices (Nitinol) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Embolic Protection Devices (Polyurethane) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Embolic Protection Devices (Polyurethane) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: Embolic Protection Devices (Disposable Devices) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: Embolic Protection Devices (Disposable Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Global: Embolic Protection Devices (Re-Usable Devices) Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Global: Embolic Protection Devices (Re-Usable Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Global: Embolic Protection Devices (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Global: Embolic Protection Devices (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Global: Embolic Protection Devices (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Global: Embolic Protection Devices (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Global: Embolic Protection Devices (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Global: Embolic Protection Devices (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: North America: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: North America: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: United States: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: United States: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Canada: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Canada: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Asia Pacific: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Asia Pacific: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: China: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: China: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Japan: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Japan: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: India: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: India: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: South Korea: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: South Korea: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Australia: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Australia: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Indonesia: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Indonesia: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Others: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Others: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Europe: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Europe: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Germany: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Germany: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: France: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: France: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: United Kingdom: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: United Kingdom: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Italy: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Italy: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Spain: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Spain: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Russia: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Russia: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Others: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Others: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Latin America: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Latin America: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Brazil: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 88: Brazil: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 89: Mexico: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 90: Mexico: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 91: Others: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 92: Others: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 93: Middle East and Africa: Embolic Protection Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 94: Middle East and Africa: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 95: Global: Embolic Protection Devices Industry: SWOT Analysis
Figure 96: Global: Embolic Protection Devices Industry: Value Chain Analysis
Figure 97: Global: Embolic Protection Devices Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Embolic Protection Devices Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Embolic Protection Devices Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: Global: Embolic Protection Devices Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Embolic Protection Devices Market Forecast: Breakup by Procedure (in Million USD), 2025-2033
Table 5: Global: Embolic Protection Devices Market Forecast: Breakup by Material (in Million USD), 2025-2033
Table 6: Global: Embolic Protection Devices Market Forecast: Breakup by Usage (in Million USD), 2025-2033
Table 7: Global: Embolic Protection Devices Market Forecast: Breakup by End-User (in Million USD), 2025-2033
Table 8: Global: Embolic Protection Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 9: Global: Embolic Protection Devices Market: Competitive Structure
Table 10: Global: Embolic Protection Devices Market: Key Players

02-2729-4219

+886-2-2729-4219